Heart transplant breakthrough? common virus may predict rejection risk
NCT ID NCT05064462
First seen Mar 21, 2026 · Last updated Apr 29, 2026 · Updated 4 times
Summary
This study followed 60 heart transplant patients for one year to see if the level of a harmless virus called TTV in their blood could predict when they might get an infection or reject the new heart. Researchers measured TTV levels monthly and compared them to actual infections and rejection episodes. The goal was to find a simple blood test that could help doctors personalize anti-rejection medicine and prevent complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Strasbourg
Strasbourg, 67091, France
-
CHU de Rennes
Rennes, 35033, France
-
Hôpital européen Georges Pompidou
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.